Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Moricizine MeSH Descriptor Data 2025


MeSH Heading
Moricizine
Tree Number(s)
D02.886.369.533
D03.383.533.640.475
D03.633.300.783.533
Unique ID
D016293
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016293
Scope Note
An antiarrhythmia agent used primarily for ventricular rhythm disturbances.
Entry Term(s)
EN-313
Ethmozin
Ethmozine
Etmozin
Moracizin
Moracizine
Moricizine Hydrochloride
Pharm Action
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Registry Numbers
2GT1D0TMX1
0
71OK3Z1ESP
Related Numbers
29560-58-5
31883-05-3
71OK3Z1ESP
CAS Type 1 Name
Carbamic acid, (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)-, ethyl ester
Previous Indexing
Anti-Arrhythmia Agents (1966-1990)
Morpholines (1966-1990)
Phenothiazines (1966-1990)
Public MeSH Note
91
History Note
91
Date Established
1991/01/01
Date of Entry
1990/05/29
Revision Date
2018/07/05
Moricizine Preferred
Ethmozine Narrower
EN-313 Narrower
Moricizine Hydrochloride Narrower
page delivered in 0.123s